Closed
1.95 10.8
24h
Min
1.65
Max
2
Income | 1.3M -13M |
---|---|
EPS | -0.2 |
Employees | 34 |
EBITDA | 1.3M -13M |
Recommendations | Strong Buy |
---|---|
12 Months Forecast | +550.51% upside |
Next Earnings | 7 May 2025 |
---|
Market Cap | 29M 116M |
---|---|
Previous open | -8.85 |
Previous close | 1.95 |
Past performance is not a reliable indicator of future results.
Price change
By TipRanks
12 Months Forecast
Average 12.75 USD 550.51%
High 28 USD
Low 6 USD
Based on 5 Wall Street analysts offering 12 month price targets forRegulus Therapeutics Inc - Dist in the last 3 months.
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$